Downloads

  1. Governance In Action: Aligning Stakeholders To Safeguard Patient Safety 6/3/2026

    Strong governance and collaboration among investigators, monitors, and safety teams enhance oversight, improve data quality, and speed responses to safety events — protecting patients in clinical trials.

  2. Closing The Gaps: Strengthening Safety Data Flow In Outsourced Clinical Trials 6/3/2026

    Outsourced clinical trials risk safety missteps when communication falters. Clear, detailed data flow processes help prevent lost context, reduce misclassification, and support more accurate safety decisions across CROs and internal teams.

  3. How To Escape The AI Pilot Trap 6/3/2026

    Agentic AI promises proactive recommendations, cross-functional coordination, and faster decisions, but deploying it effectively requires alignment, oversight, and stakeholder buy-in.

  4. Building A Scalable Oncology Engine In A Dynamic Market 6/3/2026

    Learn how a top-10 global pharmaceutical company partnered with Medable to rapidly scale the number of oncology trials it could concurrently conduct.

  5. Lessons In Pivoting From A Clinical Trial Launch In Uganda 6/3/2026

    Gates MRI researchers share how they navigated supply chain challenges, an Ebola outbreak, and evolving regional malaria vaccination strategies to successfully execute a malaria clinical trial in Uganda.

  6. DDW 2026 Signalled The Next Era Of Competitive Landscape In IBD 6/2/2026

    At the DDW 2026 meeting, the IBD landscape was portrayed as increasingly competitive and diversified, with emerging players and novel mechanisms challenging established standards of care.

  7. What Is Computer Software Assurance, And What Are Its Benefits? 6/2/2026

    Kamila Novak reviews final computer software assurance (CSA) guidance and what it means for those working on medical device clinical trials.

  8. The FDA Is Rudderless And Clinical Trials Are Left Adrift 6/2/2026

    Former commissioner Marty Makary, MD, left the FDA in May 2026. In his wake, he left an agency facing yet another wave of uncertainty. Denise N. Bronner attempts to navigate the latest change and offers advice for those seeking stability.

  9. Expanding Access To Cell Therapy Trials Beyond AMCs And Into The Community 6/1/2026

    CEO Paul J. Hastings discusses Nkarta's decision to bring outpatient dosing into the community setting, including how it communicated with the FDA on safety and how the changes will improve patient access. 

  10. What's The Role Of HEOR For A Clinical Researcher? A Perspective From ISPOR 2026 6/1/2026

    On the heels of ISPOR 2026, discover what relevancy HEOR has in the world of clinical operations.